2-(6-chloro-5-methylpyridin-3-yl)acetonitrile | 913839-52-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(6-chloro-5-methylpyridin-3-yl)acetonitrile
• 英文别名: (6-chloro-5-methylpyridin-3-yl)acetonitrile
• CAS: 913839-52-8
• 化学式: C₈H₇ClN₂
• mdl: MFCD09924115
• 分子量: 166.61
• InChiKey: OXWXTQSNABDJET-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(6-chloro-5-methylpyridin-3-yl)acetonitrile 在 硫酸 、 水 、 sodium carbonate 作用下， 以 水 为溶剂， 生成 2-(6-chloro-5-methylpyridin-3-yl)acetic acid
  参考文献：
  名称：

  [EN] N- (HETERO)ARYL, 2- (HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS
  [FR] ACÉTAMIDES À SUBSTITUTION N-(HÉTÉRO)ARYL, 2-(HÉTÉRO)ARYLE POUR UNE UTILISATION EN TANT QUE MODULATEURS DE LA VOIE DE SIGNALISATION WNT

  摘要：

  本发明涉及公式1和2的化合物，以及使用这些化合物调节Wnt信号通路的方法，其中A1、A2、B、Y和Z都代表环。

  公开号：

  WO2010101849A1
• 作为产物：
  描述：

  2-甲基-2-丁烯腈 在 sodium tetrahydroborate 、 氯化亚砜 、 potassium carbonate 、 potassium iodide 、 三氯氧磷 作用下， 以 甲醇 、 二氯甲烷 、 乙腈 为溶剂， 反应 23.0h， 生成 2-(6-chloro-5-methylpyridin-3-yl)acetonitrile
  参考文献：
  名称：

  Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system

  摘要：

  The Wnt signaling pathway is a critical developmental pathway which operates through control of cellular functions such as proliferation and differentiation. Aberrant Wnt signaling has been linked to the formation and metastasis of tumors. Porcupine, a member of the membrane -bound O-acyltransferase family of proteins, is an important component of the Wnt pathway. Porcupine catalyzes the palmitoylation of Wnt proteins, a process needed for their secretion and activity. Here we report a novel series of compounds obtained by a scaffold hybridization strategy from a known porcupine inhibitor class. The leading compound 59 demonstrated subnanomolar inhibition of Wnt signaling in a paracrine cellular assay. Compound 59 also showed excellent chemical, plasma and liver microsomal stabilities. Furthermore, compound 59 exhibited good pharmacokinetic profiles with 30% oral bioavailability in rat. Collectively, these results strongly support further optimization of this novel scaffold to develop better Wnt pathway inhibitors. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.11.026

文献信息

• [EN] N- (HETERO)ARYL, 2- (HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS<br/>[FR] ACÉTAMIDES À SUBSTITUTION N-(HÉTÉRO)ARYL, 2-(HÉTÉRO)ARYLE POUR UNE UTILISATION EN TANT QUE MODULATEURS DE LA VOIE DE SIGNALISATION WNT
  申请人：IRM LLC

  公开号：WO2010101849A1

  公开（公告）日：2010-09-10

  The present invention relates to compounds of formulae 1 and 2 and methods for modulating the Wnt signaling pathway using these compounds, wherein A1, A2, B, Y and Z all represent rings.

  本发明涉及公式1和2的化合物，以及使用这些化合物调节Wnt信号通路的方法，其中A1、A2、B、Y和Z都代表环。
• Dipyridyl-dihydropyrazolones and their use
  申请人：Flamme Ingo

  公开号：US20100035906A1

  公开（公告）日：2010-02-11

  The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

  本申请涉及新型二吡啶基-二氢吡唑酮化合物，其制备方法，其用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物，特别是心血管和血液疾病、肾脏疾病和促进伤口愈合的药物。
• N- (HETERO)ARYL, 2- (HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS
  申请人：Cheng Dai

  公开号：US20110237573A1

  公开（公告）日：2011-09-29

  The present invention relates to compounds of formulae 1 and 2 and methods for modulating the Wnt signaling pathway using these compounds, wherein A 1 , A 2 , B, Y and Z all represent rings.

  本发明涉及公式1和2的化合物以及使用这些化合物调节Wnt信号通路的方法，其中A1、A2、B、Y和Z均表示环。
• SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES
  申请人：FLAMME Ingo

  公开号：US20120322772A1

  公开（公告）日：2012-12-20

  The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

  本申请涉及新型的二吡啶基-二氢吡唑酮化合物，其制备方法，用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物，特别是心血管疾病、血液学疾病和肾脏疾病，以及促进伤口愈合的用途。
• N-(HETERO)ARYL, 2-(HETERO)ARYL-SUBSTITUTED ACETAMIDES FOR USE AS WNT SIGNALING MODULATORS
  申请人：Cheng Dai

  公开号：US20130310375A1

  公开（公告）日：2013-11-21

  The present invention relates to compositions and methods for modulating the Wnt signaling pathway.

  本发明涉及用于调节Wnt信号通路的组合物和方法。